AP ARS Pharmaceuticals, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the ARS Pharmaceuticals, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €585.7m. The latest transaction was filed on 31 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Lowenthal Richard E. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,930 of 29,062 companies
FCF yld -29%
Earn yld -29%
EV/EBITDA ·
ROE -210%
Gross mgn 76%
Net mgn ·
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
All Executives139 Thresholds0 Prospectus0 Other0
Declarations 139 total
● Officer, 10% Stockholder · Executives · 31 Aug 2026
63,289 shares @ US$5.8162 Common SEC144:0001950047-26-008852
● Officer, Director, 10% Stockholder · Executives · 20 Aug 2026
25,000 shares @ US$5.9264 0.024% mcap 18.7% of flow Common SEC144:0001950047-26-008459
● Officer, 10% Stockholder · Executives · 20 Aug 2026
25,000 shares @ US$5.9188 0.024% mcap 23.7% of flow Common SEC144:0001950047-26-008488
● Officer, Director, 10% Stockholder · Executives · 19 Aug 2026
50,000 shares @ US$6.4469 0.052% mcap 50.5% of flow Common SEC144:0001950047-26-008376
● Officer, 10% Stockholder · Executives · 19 Aug 2026
25,000 shares @ US$6.4468 0.026% mcap 34.1% of flow Common SEC144:0001950047-26-008389
● Officer, Director, 10% Stockholder · Executives · 18 Aug 2026
50,000 shares @ US$6.3177 0.050% mcap 100.0% of flow Common SEC144:0001950047-26-008357
● Officer, 10% Stockholder · Executives · 18 Aug 2026
49,401 shares @ US$6.2993 0.050% mcap 100.0% of flow Common SEC144:0001950047-26-008362
● Officer · Executives · 12 Jun 2026
3,355 shares @ US$10.00 0.0042% mcap 100.0% of flow Common SEC144:0001950047-26-005998
● Officer · Executives · 12 Jun 2026
25,000 shares @ US$10.00 0.031% mcap 100.0% of flow Common SEC144:0001950047-26-006004
▼ Chief Legal Officer · Executives · 12 Jun 2026
3,355 shares Common Stock SEC:0001398595-26-000004:0
◇ Chief Commercial Officer · Executives · 12 Jun 2026
25,000 shares Common Stock SEC:0001951287-26-000004:0
▼ Chief Commercial Officer · Executives · 12 Jun 2026
25,000 shares Common Stock SEC:0001951287-26-000004:1
● Director · Executives · 12 Nov 2025
250,000 shares 0Common Stock SEC:0001580787-25-000004:0
◇ Chief Operating Officer · Executives · 13 Nov 2025
21,828 shares @ US$0.64 17.9% of flow Common Stock SEC:0001380762-25-000005:0
◇ Chief Business Officer · Executives · 12 Nov 2025
30,000 shares @ US$0.84 3.3% of flow Common Stock SEC:0001951238-25-000005:0
▼ PRESIDENT AND CEO · Executives · 21 Aug 2025
50,000 shares @ US$14.4869 6.5% of flow Common Stock SEC:0001415889-25-022761:0
◇ Chief Financial Officer · Executives · 21 Aug 2025
12,500 shares @ US$1.50 9.7% of flow Common Stock SEC:0001415889-25-022760:0
▼ CHIEF MEDICAL OFFICER · Executives · 19 Aug 2025
12,344 shares @ US$14.0254 1.6% of flow Common Stock SEC:0001415889-25-022638:0
◇ Chief Commercial Officer · Executives · 1 Jul 2025
15,000 shares @ US$1.50 22.5% of flow Common Stock SEC:0001415889-25-019321:0
▼ 10% Owner · Executives · 27 Jun 2025
370,075 shares @ US$18.46 47.3% of flow Class A Common Stock SEC:0001193805-25-000959:0
▼ 10% Owner · Executives · 27 Jun 2025
370,074 shares @ US$18.46 47.3% of flow Class A Common Stock SEC:0001193805-25-000959:1
◇ Chief Commercial Officer · Executives · 18 Jun 2025
15,000 shares @ US$1.50 29.9% of flow Common Stock SEC:0001415889-25-017901:0
◇ Director · Executives · 20 May 2025
120,000 shares @ US$1.01 100.0% of flow Common Stock SEC:0001415889-25-014185:0
◇ Chief Legal Officer · Executives · 20 May 2025
100,000 shares @ US$5.58 78.3% of flow Common Stock SEC:0001415889-25-014186:0
◇ Chief Financial Officer · Executives · 20 May 2025
50,000 shares @ US$1.50 44.2% of flow Common Stock SEC:0001415889-25-014184:0
25 of 139 declarations
Load more (114 remaining) 关于 ARS Pharmaceuticals, Inc. ARS Pharmaceuticals, Inc. 是一家专注于开发过敏和呼吸道疾病治疗方法的公司。该公司在纳斯达克上市，股票代码为 ARS。